Synopsis
0
CEP/COS
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
Zeon Pharma is a manufacturer and supplier of APIs & Intermediates.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
50
PharmaCompass offers a list of Mosapride Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mosapride Citrate manufacturer or Mosapride Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mosapride Citrate manufacturer or Mosapride Citrate supplier.
A Mosapride Citrate Dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mosapride Citrate Dihydrate, including repackagers and relabelers. The FDA regulates Mosapride Citrate Dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mosapride Citrate Dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mosapride Citrate Dihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Mosapride Citrate Dihydrate supplier is an individual or a company that provides Mosapride Citrate Dihydrate active pharmaceutical ingredient (API) or Mosapride Citrate Dihydrate finished formulations upon request. The Mosapride Citrate Dihydrate suppliers may include Mosapride Citrate Dihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Mosapride Citrate Dihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Mosapride Citrate Dihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Mosapride Citrate Dihydrate active pharmaceutical ingredient (API) in detail. Different forms of Mosapride Citrate Dihydrate DMFs exist exist since differing nations have different regulations, such as Mosapride Citrate Dihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mosapride Citrate Dihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Mosapride Citrate Dihydrate USDMF includes data on Mosapride Citrate Dihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mosapride Citrate Dihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mosapride Citrate Dihydrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Mosapride Citrate Dihydrate Drug Master File in Japan (Mosapride Citrate Dihydrate JDMF) empowers Mosapride Citrate Dihydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Mosapride Citrate Dihydrate JDMF during the approval evaluation for pharmaceutical products. At the time of Mosapride Citrate Dihydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Mosapride Citrate Dihydrate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mosapride Citrate Dihydrate Drug Master File in Korea (Mosapride Citrate Dihydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mosapride Citrate Dihydrate. The MFDS reviews the Mosapride Citrate Dihydrate KDMF as part of the drug registration process and uses the information provided in the Mosapride Citrate Dihydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mosapride Citrate Dihydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mosapride Citrate Dihydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mosapride Citrate Dihydrate suppliers with KDMF on PharmaCompass.
A Mosapride Citrate Dihydrate written confirmation (Mosapride Citrate Dihydrate WC) is an official document issued by a regulatory agency to a Mosapride Citrate Dihydrate manufacturer, verifying that the manufacturing facility of a Mosapride Citrate Dihydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Mosapride Citrate Dihydrate APIs or Mosapride Citrate Dihydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Mosapride Citrate Dihydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Mosapride Citrate Dihydrate suppliers with Written Confirmation (WC) on PharmaCompass.
Mosapride Citrate Dihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mosapride Citrate Dihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mosapride Citrate Dihydrate GMP manufacturer or Mosapride Citrate Dihydrate GMP API supplier for your needs.
A Mosapride Citrate Dihydrate CoA (Certificate of Analysis) is a formal document that attests to Mosapride Citrate Dihydrate's compliance with Mosapride Citrate Dihydrate specifications and serves as a tool for batch-level quality control.
Mosapride Citrate Dihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Mosapride Citrate Dihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mosapride Citrate Dihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Mosapride Citrate Dihydrate EP), Mosapride Citrate Dihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mosapride Citrate Dihydrate USP).
